Delivery Order SPE2DB22D3301-SPE2DB24FX3GC
Award Date
10/5/23
Potential Completion Date
10/6/23
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,989.06, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,667.52, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,931.72 firm-fixed-price delivery order is for the medical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML" and has a completion date of February 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,211.10, is a delivery order for the medication KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The contract has an ultimate completion date of November 29, 2024 and is a firm fixed-price arrangement. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,233.05, is a delivery order under a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a delivery order (SPE2DB22D3501|SPE2DB25FUG98) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,448.28 firm fixed-price contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of January 27, 2025 and was awarded on January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,089.60 firm fixed-price delivery order (SPE2DB20D1050|SPE2DB25FH48L) is for the supply of 4567145496 ! KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, with a performance period through February 5, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,071.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply KONVOMEP 2-84 MG/ML oral suspension (90 ml). This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The delivery order is for $4,743.00 and has a performance period through May 24, 2023. This award does not have a set-aside designation, indicating full and open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...